Members
centres of competence
Banner

Spacer

Banner

Spacer

Spacer

Spacer

Spacer

Spacer

  • AKM, Aachen competence center for medical technology: Initiated in 2000 by the German Ministry of Research and Education, AKM is one of eight competence centers for medical technology in Germany. It aims to consequently translate scientific results into economic application. AKM supports the great potential of ideas at the Universities and research institutions as well as the number of innovative start-ups.

 

  • Bioconnection: based in Oss, was established in 2005 as a joint initiative of government authorities in The Netherlands and the private industry. The company aims to be a stepping stone for young biotech companies, to promote innovation in the biotech sector and to strengthen the European biotech infrastructure. With services and manufacturing facilities available within a one-stop-shop concept, BioConnection is the central point for young biotech companies to turn to for all aspects of biopharmaceutical development and manufacturing.  

 

  • BWA, Aachen competence center for biomaterials: The centre of competence established at RWTH Aachen has the task of integrating the basic research, materials, R&D and industrial production in the field of biomaterials. The project areas are cross-disciplinary. Researchers from the natural sciences, engineering and medical faculties have already been working together successfully for over ten years in the field of "Materials in Medical Technology". The main goal of the projects is the development of implants in cooperation with the industry.

 


 

  • Center for Translational Molecular Medicine (CTMM) – Eindhoven:

    The Center for Translational Molecular Medicine (CTMM) is to receive a €150 million grant from the Dutch government according to an announcement made September 19 during the presentation of the 2007 National Budget. The all-time highest support ever granted to a public private partnership in the Netherlands, the contribution will be drawn from what is known as the Economic Structure Enhancing Fund (FES), which aims to finance investment projects of national significance to strengthen the Netherlands’ economic structure.
    Taking the initiative and serving as key participants in the CTMM are the businesses Philips, Organon, DSM and FEI, as well as the Medical Centers of Erasmus University, University of Groningen, Radboud University in Nijmegen, the Free University, University of Utrecht, University of Maastricht, Technical University of Eindhoven and the Netherlands Cancer Institute (NKI). In addition, more than thirty other organizations, including small and medium-sized businesses, have signed letters of intent and statements of support pledging assistance to the CTMM initiative. Other supporters of the CTMM include the Netherlands Heart Foundation, The Dutch Cancer Society and the Netherlands Alzheimer Foundation.
    The CTMM is a public-private partnership able to conduct innovative, groundbreaking research into molecular medicine by combining forces and expertise. Molecular medicine is revolutionizing healthcare. A greater understanding of genetics and molecular biology and biochemistry, combined with new technologies, will give birth to groundbreaking medical applications.
    New medical solutions will be developed which will be scientifically, clinically and economically relevant using an integrated approach, from fundamental research into molecular medicine to initial validation of clinical applicability in hospitals. The use of innovative medical technologies is a central part of the implementation of molecular medicine.

    Research will focus on cancer and cardiovascular diseases - the two leading causes of death in the Netherlands, accounting for a combined total of nearly two thirds of all fatalities. Neurodegenerative diseases like Alzheimer’s will also be studied. These illnesses result in a huge drop in the quality of life and will have an increasing impact as the population ages. Finally, attention will be devoted to infectious diseases, which are responsible for a significant number of intensive care deaths in the Netherlands and are of potentially great significance given the threat of pandemics such as the avian flu. The starting date for the first research projects was the 1st of January 2007. The CTMM is headquartered on the High Tech Campus in Eindhoven.

 

  • Dutch Polymer Institute (Eindhoven) DPI is a foundation funded by industry, universities and government set up to perform exploratory research in the area of polymer materials. DPI operates at the interface of universities and industry, linking the scientific skills of university research groups to industrial need for innovation. DPI performs pre-competitive research projects to add value to the scientific community through scientific publications and to the industrial community through the creation of intellectual property.

 

  • Embedded systems institute (Eindhoven) The Embedded Systems Institute, located at the TU/e campus, has the explicit aim of making the knowledge about embedded systems publicly available. The ambition of the institute is to become a leading expertise center for embedded systems.

 

  • GIGA, Interdisciplinary Group of Applied Genoproteomics Ličge: In order to continue to foster applied proteo-genomics, the University of Ličge has set up an interdisciplinary research group. GIGA aims at developing a new environment to foster industrial biomedical activities. At its heart is the CBIG research centre with 24 research units and 260 staff, equipped with technological facilities available for academics and private companies. Furthermore, an incubator for biomedical spin-offs and space dedicated to biomedical companies are under development. GIGA means targeted research funding and also plans to finance pre-competitive research in the biomedical field.

 

  • GROW, Research Institute Growth and Development: This institute aims to carry out high quality scientific research in the field of early human development (normal and abnormal growth and differentiation) and in the field of oncology (abnormal growth and differentiation).

 

  • Helmholtz-Institute for Biomedical Engineering: Since its foundation in the year 1971 the Helmholtz - Institute for Biomedical Engineering as an institute of RWTH Aachen University has been acting as a bridge between the faculties of natural sciences and engineering and the medical disciplines. In 2002 the Institute was restructured fundamentally and set up as a faculty spanning consortium. The new Helmholtz – Institute for Biomedical Engineering is now being sustained by the Faculty of Mathematics, Computer Sciences and Natural Sciences, the Faculty of Mechanical Engineering, the Faculty of Electrical Engineering and Information Technology and the Faculty of Medicine.

 

  • High Tech Campus Eindhoven: Open innovation is all about collaboration. With the current state of technology, a one-firm solution is a thing of the past. Specialist companies, knowledge institutes and governments increasingly join forces. This has its benefits. Using each other’s strengths, knowledge, experience and expensive research equipment will result in efficient and effective technology developments. Combining views and visions will create synergy. The success rate of new initiatives that emerge from open innovation is substantially higher than the success rate of closed research centres. Open innovation also creates space for specialist companies to develop their core business at a high level and to market new products effectively. High Tech Campus Eindhoven has created an ecosystem that focuses on open innovation – with a network that extends way beyond Eindhoven

 

  • Holst Centre: The Holst Center, situated at the High Tech Campus Eindhoven, is an independent R&D institute in the field of functional materials, devices and microsystems. One of the Center’s applications is ‘healthcare and lifestyle’. A key feature of the Center is interaction and co-operation with industry and academia. It is this kind of cross-fertilization that will enable the Holst Center to tune its scientific strategy to industrial needs. The Center’s initiators are IMEC (www.imec.be ), a world leading independent research center in nanoelectronics and nanotechnology and TNO, the Dutch independent R&D organization (www.tno.nl ).

 

  • IME, Fraunhofer-Institute for Molecular Biotechnology and Applied Ecology: IME conducts research in the field of applied life sciences from a molecular level to entire ecosystems. The institute offers research and development services for medicine, agriculture and environmental protection with main emphasis on diagnosis and therapy of human, animal and plant diseases, protection and improvement of food and feed stocks, identification and assessment of risks in synthetic and biogenous substances for consumer and environment and the development of strategies for minimization of risks.

 

  • Miplaza (Eindhoven) Located at the High Tech Campus Eindhoven, MiPlaza (Microsystems Plaza) offers world-class research facilities, services and expertise to facilitate innovation and create a value network for high tech organizations in the domains of micro-systems, nano-technology, electronic systems, high tech equipment and life sciences.

 

  • NUTRIM, Nutrition and Toxicology Research Institute Maastricht: This institute with 200 scientists is renowned for sport nutrients and clinical nutrition. Nutrition research within NUTRIM focuses particularly on research questions concerning the effects of nutrition, nutritional components and nutritional behaviour on the health of man.